sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

Category : Pharmaceuticals and Healthcare QY Research Pages :118
Published Date : 2020-09-16

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Prophylactic Human Vaccine Market with our analysts monitoring the situation across the globe.
Prophylactic Human Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Prophylactic Human Vaccine market is segmented into Inactivated Vaccine Attenuated Vaccine Others Segment by Application, the Prophylactic Human Vaccine market is segmented into Hospital Scientific Research Others Regional and Country-level Analysis The Prophylactic Human Vaccine market is analysed and market size information is provided by regions (countries). The key regions covered in the Prophylactic Human Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Prophylactic Human Vaccine Market Share Analysis Prophylactic Human Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prophylactic Human Vaccine business, the date to enter into the Prophylactic Human Vaccine market, Prophylactic Human Vaccine product introduction, recent developments, etc. The major vendors covered: GSK Biovac McKesson Medical Merck Merial Zoetis Sanofi ...
1 Study Coverage 1.1 Prophylactic Human Vaccine Product Introduction 1.2 Market Segments 1.3 Key Prophylactic Human Vaccine Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Type 1.4.2 Inactivated Vaccine 1.4.3 Attenuated Vaccine 1.4.4 Others 1.5 Market by Application 1.5.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Application 1.5.2 Hospital 1.5.3 Scientific Research 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Prophylactic Human Vaccine Industry Impact 1.6.1 How the Covid-19 is Affecting the Prophylactic Human Vaccine Industry 1.6.1.1 Prophylactic Human Vaccine Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Prophylactic Human Vaccine Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Prophylactic Human Vaccine Market Size Estimates and Forecasts 2.1.1 Global Prophylactic Human Vaccine Revenue 2015-2026 2.1.2 Global Prophylactic Human Vaccine Sales 2015-2026 2.2 Prophylactic Human Vaccine Market Size by Region: 2020 Versus 2026 2.2.1 Global Prophylactic Human Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Prophylactic Human Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Prophylactic Human Vaccine Competitor Landscape by Players 3.1 Prophylactic Human Vaccine Sales by Manufacturers 3.1.1 Prophylactic Human Vaccine Sales by Manufacturers (2015-2020) 3.1.2 Prophylactic Human Vaccine Sales Market Share by Manufacturers (2015-2020) 3.2 Prophylactic Human Vaccine Revenue by Manufacturers 3.2.1 Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020) 3.2.2 Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Prophylactic Human Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Prophylactic Human Vaccine Revenue in 2019 3.2.5 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Prophylactic Human Vaccine Price by Manufacturers 3.4 Prophylactic Human Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Prophylactic Human Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into Prophylactic Human Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Prophylactic Human Vaccine Market Size by Type (2015-2020) 4.1.1 Global Prophylactic Human Vaccine Sales by Type (2015-2020) 4.1.2 Global Prophylactic Human Vaccine Revenue by Type (2015-2020) 4.1.3 Prophylactic Human Vaccine Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Prophylactic Human Vaccine Market Size Forecast by Type (2021-2026) 4.2.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2021-2026) 4.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Type (2021-2026) 4.2.3 Prophylactic Human Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Prophylactic Human Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Prophylactic Human Vaccine Market Size by Application (2015-2020) 5.1.1 Global Prophylactic Human Vaccine Sales by Application (2015-2020) 5.1.2 Global Prophylactic Human Vaccine Revenue by Application (2015-2020) 5.1.3 Prophylactic Human Vaccine Price by Application (2015-2020) 5.2 Prophylactic Human Vaccine Market Size Forecast by Application (2021-2026) 5.2.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2021-2026) 5.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Application (2021-2026) 5.2.3 Global Prophylactic Human Vaccine Price Forecast by Application (2021-2026) 6 North America 6.1 North America Prophylactic Human Vaccine by Country 6.1.1 North America Prophylactic Human Vaccine Sales by Country 6.1.2 North America Prophylactic Human Vaccine Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Prophylactic Human Vaccine Market Facts & Figures by Type 6.3 North America Prophylactic Human Vaccine Market Facts & Figures by Application 7 Europe 7.1 Europe Prophylactic Human Vaccine by Country 7.1.1 Europe Prophylactic Human Vaccine Sales by Country 7.1.2 Europe Prophylactic Human Vaccine Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Prophylactic Human Vaccine Market Facts & Figures by Type 7.3 Europe Prophylactic Human Vaccine Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Prophylactic Human Vaccine by Region 8.1.1 Asia Pacific Prophylactic Human Vaccine Sales by Region 8.1.2 Asia Pacific Prophylactic Human Vaccine Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Type 8.3 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Application 9 Latin America 9.1 Latin America Prophylactic Human Vaccine by Country 9.1.1 Latin America Prophylactic Human Vaccine Sales by Country 9.1.2 Latin America Prophylactic Human Vaccine Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Type 9.3 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Prophylactic Human Vaccine by Country 10.1.1 Middle East and Africa Prophylactic Human Vaccine Sales by Country 10.1.2 Middle East and Africa Prophylactic Human Vaccine Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Type 10.3 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Application 11 Company Profiles 11.1 GSK 11.1.1 GSK Corporation Information 11.1.2 GSK Description, Business Overview and Total Revenue 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020) 11.1.4 GSK Prophylactic Human Vaccine Products Offered 11.1.5 GSK Recent Development 11.2 Biovac 11.2.1 Biovac Corporation Information 11.2.2 Biovac Description, Business Overview and Total Revenue 11.2.3 Biovac Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Biovac Prophylactic Human Vaccine Products Offered 11.2.5 Biovac Recent Development 11.3 McKesson Medical 11.3.1 McKesson Medical Corporation Information 11.3.2 McKesson Medical Description, Business Overview and Total Revenue 11.3.3 McKesson Medical Sales, Revenue and Gross Margin (2015-2020) 11.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered 11.3.5 McKesson Medical Recent Development 11.4 Merck 11.4.1 Merck Corporation Information 11.4.2 Merck Description, Business Overview and Total Revenue 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Merck Prophylactic Human Vaccine Products Offered 11.4.5 Merck Recent Development 11.5 Merial 11.5.1 Merial Corporation Information 11.5.2 Merial Description, Business Overview and Total Revenue 11.5.3 Merial Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Merial Prophylactic Human Vaccine Products Offered 11.5.5 Merial Recent Development 11.6 Zoetis 11.6.1 Zoetis Corporation Information 11.6.2 Zoetis Description, Business Overview and Total Revenue 11.6.3 Zoetis Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Zoetis Prophylactic Human Vaccine Products Offered 11.6.5 Zoetis Recent Development 11.7 Sanofi 11.7.1 Sanofi Corporation Information 11.7.2 Sanofi Description, Business Overview and Total Revenue 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Sanofi Prophylactic Human Vaccine Products Offered 11.7.5 Sanofi Recent Development 11.1 GSK 11.1.1 GSK Corporation Information 11.1.2 GSK Description, Business Overview and Total Revenue 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020) 11.1.4 GSK Prophylactic Human Vaccine Products Offered 11.1.5 GSK Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Prophylactic Human Vaccine Market Estimates and Projections by Region 12.1.1 Global Prophylactic Human Vaccine Sales Forecast by Regions 2021-2026 12.1.2 Global Prophylactic Human Vaccine Revenue Forecast by Regions 2021-2026 12.2 North America Prophylactic Human Vaccine Market Size Forecast (2021-2026) 12.2.1 North America: Prophylactic Human Vaccine Sales Forecast (2021-2026) 12.2.2 North America: Prophylactic Human Vaccine Revenue Forecast (2021-2026) 12.2.3 North America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026) 12.3 Europe Prophylactic Human Vaccine Market Size Forecast (2021-2026) 12.3.1 Europe: Prophylactic Human Vaccine Sales Forecast (2021-2026) 12.3.2 Europe: Prophylactic Human Vaccine Revenue Forecast (2021-2026) 12.3.3 Europe: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Prophylactic Human Vaccine Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Prophylactic Human Vaccine Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Prophylactic Human Vaccine Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Prophylactic Human Vaccine Market Size Forecast by Region (2021-2026) 12.5 Latin America Prophylactic Human Vaccine Market Size Forecast (2021-2026) 12.5.1 Latin America: Prophylactic Human Vaccine Sales Forecast (2021-2026) 12.5.2 Latin America: Prophylactic Human Vaccine Revenue Forecast (2021-2026) 12.5.3 Latin America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Prophylactic Human Vaccine Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Prophylactic Human Vaccine Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Prophylactic Human Vaccine Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Prophylactic Human Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

Get Free Sample

List of Tables Table 1. Prophylactic Human Vaccine Market Segments Table 2. Ranking of Global Top Prophylactic Human Vaccine Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Prophylactic Human Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Inactivated Vaccine Table 5. Major Manufacturers of Attenuated Vaccine Table 6. Major Manufacturers of Others Table 7. COVID-19 Impact Global Market: (Four Prophylactic Human Vaccine Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Prophylactic Human Vaccine Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact Table 12. Global Prophylactic Human Vaccine Market Size Growth Rate by Application 2020-2026 (K Units) Table 13. Global Prophylactic Human Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 14. Global Prophylactic Human Vaccine Sales by Regions 2015-2020 (K Units) Table 15. Global Prophylactic Human Vaccine Sales Market Share by Regions (2015-2020) Table 16. Global Prophylactic Human Vaccine Revenue by Regions 2015-2020 (US$ Million) Table 17. Global Prophylactic Human Vaccine Sales by Manufacturers (2015-2020) (K Units) Table 18. Global Prophylactic Human Vaccine Sales Share by Manufacturers (2015-2020) Table 19. Global Prophylactic Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 20. Global Prophylactic Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Human Vaccine as of 2019) Table 21. Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020) (US$ Million) Table 22. Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020) Table 23. Key Manufacturers Prophylactic Human Vaccine Price (2015-2020) (USD/Unit) Table 24. Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Prophylactic Human Vaccine Product Type Table 26. Date of International Manufacturers Enter into Prophylactic Human Vaccine Market Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans Table 28. Global Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units) Table 29. Global Prophylactic Human Vaccine Sales Share by Type (2015-2020) Table 30. Global Prophylactic Human Vaccine Revenue by Type (2015-2020) (US$ Million) Table 31. Global Prophylactic Human Vaccine Revenue Share by Type (2015-2020) Table 32. Prophylactic Human Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 33. Global Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units) Table 34. Global Prophylactic Human Vaccine Sales Share by Application (2015-2020) Table 35. North America Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units) Table 36. North America Prophylactic Human Vaccine Sales Market Share by Country (2015-2020) Table 37. North America Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million) Table 38. North America Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020) Table 39. North America Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units) Table 40. North America Prophylactic Human Vaccine Sales Market Share by Type (2015-2020) Table 41. North America Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units) Table 42. North America Prophylactic Human Vaccine Sales Market Share by Application (2015-2020) Table 43. Europe Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units) Table 44. Europe Prophylactic Human Vaccine Sales Market Share by Country (2015-2020) Table 45. Europe Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million) Table 46. Europe Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020) Table 47. Europe Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units) Table 48. Europe Prophylactic Human Vaccine Sales Market Share by Type (2015-2020) Table 49. Europe Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units) Table 50. Europe Prophylactic Human Vaccine Sales Market Share by Application (2015-2020) Table 51. Asia Pacific Prophylactic Human Vaccine Sales by Region (2015-2020) (K Units) Table 52. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region (2015-2020) Table 53. Asia Pacific Prophylactic Human Vaccine Revenue by Region (2015-2020) (US$ Million) Table 54. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020) Table 55. Asia Pacific Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units) Table 56. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Type (2015-2020) Table 57. Asia Pacific Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units) Table 58. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Application (2015-2020) Table 59. Latin America Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units) Table 60. Latin America Prophylactic Human Vaccine Sales Market Share by Country (2015-2020) Table 61. Latin Americaa Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million) Table 62. Latin America Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020) Table 63. Latin America Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units) Table 64. Latin America Prophylactic Human Vaccine Sales Market Share by Type (2015-2020) Table 65. Latin America Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units) Table 66. Latin America Prophylactic Human Vaccine Sales Market Share by Application (2015-2020) Table 67. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2015-2020) (K Units) Table 68. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Country (2015-2020) Table 69. Middle East and Africa Prophylactic Human Vaccine Revenue by Country (2015-2020) (US$ Million) Table 70. Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Prophylactic Human Vaccine Sales by Type (2015-2020) (K Units) Table 72. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Type (2015-2020) Table 73. Middle East and Africa Prophylactic Human Vaccine Sales by Application (2015-2020) (K Units) Table 74. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Application (2015-2020) Table 75. GSK Corporation Information Table 76. GSK Description and Major Businesses Table 77. GSK Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. GSK Product Table 79. GSK Recent Development Table 80. Biovac Corporation Information Table 81. Biovac Description and Major Businesses Table 82. Biovac Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Biovac Product Table 84. Biovac Recent Development Table 85. McKesson Medical Corporation Information Table 86. McKesson Medical Description and Major Businesses Table 87. McKesson Medical Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. McKesson Medical Product Table 89. McKesson Medical Recent Development Table 90. Merck Corporation Information Table 91. Merck Description and Major Businesses Table 92. Merck Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Merck Product Table 94. Merck Recent Development Table 95. Merial Corporation Information Table 96. Merial Description and Major Businesses Table 97. Merial Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Merial Product Table 99. Merial Recent Development Table 100. Zoetis Corporation Information Table 101. Zoetis Description and Major Businesses Table 102. Zoetis Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Zoetis Product Table 104. Zoetis Recent Development Table 105. Sanofi Corporation Information Table 106. Sanofi Description and Major Businesses Table 107. Sanofi Prophylactic Human Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Sanofi Product Table 109. Sanofi Recent Development Table 110. Global Prophylactic Human Vaccine Sales Forecast by Regions (2021-2026) (K Units) Table 111. Global Prophylactic Human Vaccine Sales Market Share Forecast by Regions (2021-2026) Table 112. Global Prophylactic Human Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million) Table 113. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Regions (2021-2026) Table 114. North America: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 115. North America: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 116. Europe: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 117. Europe: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 118. Asia Pacific: Prophylactic Human Vaccine Sales Forecast by Region (2021-2026) (K Units) Table 119. Asia Pacific: Prophylactic Human Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 120. Latin America: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 121. Latin America: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 122. Middle East and Africa: Prophylactic Human Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 123. Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 125. Key Challenges Table 126. Market Risks Table 127. Main Points Interviewed from Key Prophylactic Human Vaccine Players Table 128. Prophylactic Human Vaccine Customers List Table 129. Prophylactic Human Vaccine Distributors List Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Prophylactic Human Vaccine Product Picture Figure 2. Global Prophylactic Human Vaccine Sales Market Share by Type in 2020 & 2026 Figure 3. Inactivated Vaccine Product Picture Figure 4. Attenuated Vaccine Product Picture Figure 5. Others Product Picture Figure 6. Global Prophylactic Human Vaccine Sales Market Share by Application in 2020 & 2026 Figure 7. Hospital Figure 8. Scientific Research Figure 9. Others Figure 10. Prophylactic Human Vaccine Report Years Considered Figure 11. Global Prophylactic Human Vaccine Market Size 2015-2026 (US$ Million) Figure 12. Global Prophylactic Human Vaccine Sales 2015-2026 (K Units) Figure 13. Global Prophylactic Human Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Global Prophylactic Human Vaccine Sales Market Share by Region (2015-2020) Figure 15. Global Prophylactic Human Vaccine Sales Market Share by Region in 2019 Figure 16. Global Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020) Figure 17. Global Prophylactic Human Vaccine Revenue Market Share by Region in 2019 Figure 18. Global Prophylactic Human Vaccine Sales Share by Manufacturer in 2019 Figure 19. The Top 10 and 5 Players Market Share by Prophylactic Human Vaccine Revenue in 2019 Figure 20. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Prophylactic Human Vaccine Sales Market Share by Type (2015-2020) Figure 22. Global Prophylactic Human Vaccine Sales Market Share by Type in 2019 Figure 23. Global Prophylactic Human Vaccine Revenue Market Share by Type (2015-2020) Figure 24. Global Prophylactic Human Vaccine Revenue Market Share by Type in 2019 Figure 25. Global Prophylactic Human Vaccine Market Share by Price Range (2015-2020) Figure 26. Global Prophylactic Human Vaccine Sales Market Share by Application (2015-2020) Figure 27. Global Prophylactic Human Vaccine Sales Market Share by Application in 2019 Figure 28. Global Prophylactic Human Vaccine Revenue Market Share by Application (2015-2020) Figure 29. Global Prophylactic Human Vaccine Revenue Market Share by Application in 2019 Figure 30. North America Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 31. North America Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 32. North America Prophylactic Human Vaccine Sales Market Share by Country in 2019 Figure 33. North America Prophylactic Human Vaccine Revenue Market Share by Country in 2019 Figure 34. U.S. Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 35. U.S. Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Canada Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 37. Canada Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. North America Prophylactic Human Vaccine Market Share by Type in 2019 Figure 39. North America Prophylactic Human Vaccine Market Share by Application in 2019 Figure 40. Europe Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 41. Europe Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 42. Europe Prophylactic Human Vaccine Sales Market Share by Country in 2019 Figure 43. Europe Prophylactic Human Vaccine Revenue Market Share by Country in 2019 Figure 44. Germany Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 45. Germany Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. France Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 47. France Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. U.K. Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 49. U.K. Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Italy Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 51. Italy Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Russia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 53. Russia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Europe Prophylactic Human Vaccine Market Share by Type in 2019 Figure 55. Europe Prophylactic Human Vaccine Market Share by Application in 2019 Figure 56. Asia Pacific Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 57. Asia Pacific Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 58. Asia Pacific Prophylactic Human Vaccine Sales Market Share by Region in 2019 Figure 59. Asia Pacific Prophylactic Human Vaccine Revenue Market Share by Region in 2019 Figure 60. China Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 61. China Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Japan Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 63. Japan Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. South Korea Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 65. South Korea Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. India Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 67. India Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Australia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 69. Australia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Taiwan Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 71. Taiwan Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Indonesia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 73. Indonesia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Thailand Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 75. Thailand Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Malaysia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 77. Malaysia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Philippines Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 79. Philippines Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Vietnam Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 81. Vietnam Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Asia Pacific Prophylactic Human Vaccine Market Share by Type in 2019 Figure 83. Asia Pacific Prophylactic Human Vaccine Market Share by Application in 2019 Figure 84. Latin America Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 85. Latin America Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 86. Latin America Prophylactic Human Vaccine Sales Market Share by Country in 2019 Figure 87. Latin America Prophylactic Human Vaccine Revenue Market Share by Country in 2019 Figure 88. Mexico Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 89. Mexico Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Brazil Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 91. Brazil Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Argentina Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 93. Argentina Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Latin America Prophylactic Human Vaccine Market Share by Type in 2019 Figure 95. Latin America Prophylactic Human Vaccine Market Share by Application in 2019 Figure 96. Middle East and Africa Prophylactic Human Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 97. Middle East and Africa Prophylactic Human Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 98. Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Country in 2019 Figure 99. Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Country in 2019 Figure 100. Turkey Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 101. Turkey Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. Saudi Arabia Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 103. Saudi Arabia Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. U.A.E Prophylactic Human Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 105. U.A.E Prophylactic Human Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Middle East and Africa Prophylactic Human Vaccine Market Share by Type in 2019 Figure 107. Middle East and Africa Prophylactic Human Vaccine Market Share by Application in 2019 Figure 108. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Biovac Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. McKesson Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 112. Merial Total Revenue (US$ Million): 2019 Compared with 2018 Figure 113. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 115. North America Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 116. North America Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Europe Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 118. Europe Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Asia Pacific Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 120. Asia Pacific Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Latin America Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 122. Latin America Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 123. Middle East and Africa Prophylactic Human Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 124. Middle East and Africa Prophylactic Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 125. Porter's Five Forces Analysis Figure 126. Channels of Distribution Figure 127. Distributors Profiles Figure 128. Bottom-up and Top-down Approaches for This Report Figure 129. Data Triangulation Figure 130. Key Executives Interviewed

Get Free Sample

Related Reports

COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)